# Nawah Scientific

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/nawah-scientific

- Industry: Biotechnology
- Headquarters: Cairo, Egypt
- Website: www.nawah-scientific.com
- Total disclosed funding: $1M
- Latest round: Series A (Dec 18, 2025)
- Investors on record: 11

## About

Based in Egypt, Nawah Scientific provides high-quality scientific research services, specializing in analytical testing and formulation services to support various sectors including pharmaceuticals and food production. Founded in 2015 in Cairo, Egypt, Nawah Scientific offers scientific research services with a focus on analytical testing. In December 2025, Nawah Scientific raised USD 23 million in series A, venture debt, and grant funding from new investors Life Ventures Management, Den VC, Africinvest, Elsewedy Electric, and Empire M. Individual and other unspecified investors also participated in the round. Omar Sakr, serving as both the Founder and CEO, has been instrumental in steering the company's growth and direction.Nawah Scientific specializes in providing high-quality scientific research services, focusing on a wide array of analytical testing and formulation services. The core offerings include comprehensive analyses of vitamins, amino acids, and cellular drug uptake. Utilizing advanced methodologies such as HPLC (High-Performance Liquid Chromatography) and ELISA (Enzyme-Linked Immunosorbent Assay), the company ensures precision and reliability in its results. Nawah Scientific serves clients across various sectors, including pharmaceutical companies, food producers, and research institutions in 12 countries, including Egypt, Saudi Arabia, and Jordan.Nawah Scientific operates on a transaction-based revenue model, engaging primarily in B2B services through direct contracts with clients. Individual test fees vary based on service complexity, with vitamin analysis priced between USD 22 and USD 55 per sample, while specialized tests like Amino Acid Analysis are set at USD 125 per sample. This transactional model allows clients to select specific tests, resulting in tailored service packages that enhance customer satisfaction and repeat business. The company plans to utilize the December 2025 funding to build an R&D center in Rwanda, expand labs in Egypt and Saudi Arabia, and grow in North Africa and Europe.

## Funding rounds

- Series A, Dec 18, 2025 — Africinvest, Life Ventures Management, Den VC
- Series A, Feb 1, 2022 — Acasia
- Seed, Jan 7, 2021 — Acasia, Alexandria Angel Network, Egypt Ventures, Hult Alumni Angels, Alexandria Fund
- Seed, Dec 8, 2018, $1M — 500 Global, Endure Capital, Averroes Ventures, Egypt Ventures

## Investors

- 500 Global (https://capitalatlas.ai/funds/500-global) — Seed
- Endure Capital (https://capitalatlas.ai/funds/endure-capital) — Seed
- Averroes Ventures (https://capitalatlas.ai/funds/averroes-ventures) — Seed
- Egypt Ventures (https://capitalatlas.ai/funds/egypt-ventures) — Seed
- Acasia (https://capitalatlas.ai/funds/acasia) — Seed, Series A
- Alexandria Angel Network (https://capitalatlas.ai/funds/alexandria-angel-network) — Seed
- Hult Alumni Angels — Seed
- Alexandria Fund — Seed
- Africinvest (https://capitalatlas.ai/funds/africinvest) — Series A
- Life Ventures Management (https://capitalatlas.ai/funds/life-ventures-management) — Series A
- Den VC (https://capitalatlas.ai/funds/den-vc) — Series A